Latest News & Updates

Breaking News

  • 11 hours ago

  • Simantini Singh Deo

Amneal Launches Mesalamine And Secures FDA Approval For Generic Lenalidomide
Breaking News
Merck’s WELIREG Gains EU Approval for Advanced Kidney and VHL Tumors

Mrudula Kulkarni

Other trending news you may like to read

Chugai’s Tecentriq® Receives Approval in Japan for Unresectable Alveolar Soft Part Sarcoma

Chugai Pharmaceutical secures Japanese regulatory approval for Tecentriq® as the first immune inhibitor for unresectable alveolar soft part sarcoma.

Mrudula Kulkarni

Article

Milestone Secures Patent For CARDAMYST’s Repeat Dose Regimen

Milestone Pharmaceuticals receives USPTO Notice of Allowance, extending U.S. patent protection for CARDAMYST™ (etripamil nasal spray) until 2042.

Simantini Singh Deo

Article

Adial Pharmaceuticals Expands Patent For Genetic-Based Treatment For Addiction

Adial Pharmaceuticals expands its intellectual property with a new patent covering genetic markers for alcohol and opioid addiction treatment.

Simantini Singh Deo

Article

ImmunityBio Secures FDA Approval For Alternative BCG Supply

ImmunityBio secures FDA approval to provide an alternative BCG source amid ongoing bladder cancer treatment shortages.

Simantini Singh Deo

Article